跳至主要内容
临床试验/NCT07621276
NCT07621276已完成不适用

Frailty and Severity as Determinants of Hospital Cost in the Intensive Care Unit: A Retrospective Cohort Study With Partial Economic Evaluation.

Hospital H+ Queretaro1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2024年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
142
试验地点
1

研究概览

简要总结

This study evaluated the association between baseline frailty (mFI-11) and acute illness severity (SAPS 3) with real hospital costs in adult patients admitted to the Intensive Care Unit (ICU). The objective was to determine if frailty and severity are independent predictors of resource consumption.

详细描述

A retrospective cohort study was conducted at Hospital H+ Querétaro involving 142 adult patients admitted to the ICU between January 2024 and May 2025. Baseline frailty was calculated using the 11-item Modified Frailty Index (mFI-11), and acute severity was assessed with the SAPS 3 score. Total hospital costs were obtained from institutional financial records. Multivariate models were used to adjust for comorbidities (Charlson Index) and other clinical variables to identify independent determinants of hospital expenditure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 years or older.
  • Admission to the ICU between January 1, 2024, and May 31,
  • Complete medical records allowing for the calculation of mFI-11, SAPS 3, and Charlson Index.
  • Availability of institutional records regarding actual hospital costs.

排除标准

  • Incomplete records for primary exposure or outcome variables.
  • Patients transferred from other institutions without sufficient baseline data.
  • Severe inconsistencies in cost records.
  • Subsequent readmissions where costs cannot be independently attributed to the index episode.

研究组 & 干预措施

ICU Patient Cohort

All adult patients (≥18 years) admitted to the ICU during the study period with complete medical and financial records.

干预措施: Total Real Hospital Cost. (Other)

研究者

发起方
Hospital H+ Queretaro
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jose J Zaragoza, MD MSc

Palliative Care Specialist

Hospital H+ Queretaro

研究点 (1)

Loading locations...

相似试验